Loading...

Spexis AG

SPEX.SW•SIX
Healthcare
Biotechnology
CHF0.06
CHF0.00(0.00%)

Spexis AG (SPEX.SW) Stock Overview

Explore Spexis AG’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

F

Score: N/A

Key Financials

Market Cap3.9M
P/E RatioN/A
EPS (TTM)$-0.37
ROEN/A
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$0.02

SPEX.SW Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Spexis AG (SPEX.SW) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.02.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of N/A and a market capitalization of 3.9M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;